Abstract
Di-O-cinnamoylated, -p-coumaroylated, and -feruloylated d-, l- and meso-tartaric acids were synthesized as analogues of the natural product FR258900, a glycogen phosphorylase (GP) inhibitor with in vivo antihyperglycaemic activity. The new compounds inhibited rabbit muscle GP in the low micromolar range, and bound to the allosteric site of the enzyme. The best inhibitor was 2,3-di-O-feruloyl meso-tartaric acid and had Ki values of 2.0μM against AMP (competitive) and 3.36μM against glucose-1-phosphate (non-competitive).
Copyright © 2013 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Allosteric Site
-
Animals
-
Cinnamates / chemistry*
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / metabolism
-
Glutarates / chemistry*
-
Glycogen Phosphorylase, Muscle Form / antagonists & inhibitors*
-
Glycogen Phosphorylase, Muscle Form / metabolism
-
Hypoglycemic Agents / chemical synthesis*
-
Hypoglycemic Agents / chemistry
-
Protein Binding
-
Rabbits
-
Tartrates / chemical synthesis
-
Tartrates / chemistry*
-
Tartrates / metabolism
Substances
-
Cinnamates
-
Enzyme Inhibitors
-
FR258900
-
Glutarates
-
Hypoglycemic Agents
-
Tartrates
-
Glycogen Phosphorylase, Muscle Form
-
tartaric acid